Dr. James G. Dinulos, MD

Dr. Dinulos practices at Seacoast Dermatology, a Forefront Dermatology Practice in Portsmouth, New Hampshire.

Dr. Dinulos' NPI, 1023037579, was assigned on July 18, 2006. Dr. Dinulos graduated from Eastern Virginia Medical School in 1994. Dr. Dinulos holds New Hampshire license 10990.

Dr. Dinulos' primary practice is Seacoast Dermatology, a Forefront Dermatology Practice, at 278 Lafayette Rd, Portsmouth, NH 03801 in Rockingham County. The practice phone is (603) 431-5205.

Dr. Dinulos' primary practice is Seacoast Dermatology, a Forefront Dermatology Practice in Portsmouth, New Hampshire. The medical group on file is SeaCoast Dermatology (a Forefront Dermatology practice). Dmand AI also links Dr. Dinulos to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dinulos practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Dinulos' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dinulos is licensed in New Hampshire.

CMS data shows 3,319 Medicare services from Dr. Dinulos across 45 procedure codes in 2024, for 1,031 Medicare patients. Medicare paid $673,223 for them. Every service was in an office.

CMS counts 1,031 Medicare patients who saw Dr. Dinulos in 2024. The largest group is 75 to 84, with 429 patients. 72% of them have high cholesterol, and 66% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dinulos' median patient age at 73, with 52% women.

In 2024, Dr. Dinulos wrote 449 Medicare Part D claims for 254 patients. 93% of them were for generic drugs. CMS names the drug for 350 of them, across 12 drugs with 11 or more claims each, at $109,244 in total drug cost. In 2023, CMS named 345 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dinulos for performance year 2024, reported as part of a group. Dr. Dinulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 130 procedures of melanoma (skin cancer) excision by Dr. Dinulos, more than 95% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Dinulos, published from 2011 to 2023. 2012 was the busiest year, with 2. The most frequent topics are Skin, Skin Neoplasms and Administration, Topical. Dr. Dinulos has published most often in Curr Opin Pediatr. Dr. Dinulos' most frequent co-authors are Keith William Morley, MD, Wanda Phipatanakul, MD, MS and Nicola Ann Quatrano, MD.

CMS Open Payments shows 26 general payments to Dr. Dinulos from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 95% of the total. Merck Sharp & Dohme Corporation paid the most, $12,235.

Dr. Dinulos graduated from Eastern Virginia Medical School in 1994.